Vivozon
Manufacturing · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
357 Guseong-ro D9f/10f, Yongin-si, Gyeon...Website
www.vivozon.comRevenue
$6.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Vivozon
VIVOZON is a pharmaceutical company specializing in the development of innovative non-narcotic analgesics, including Opiranserin (VVZ-149), aimed at treating pain and central nervous system disorders such as depression, anxiety, and addiction. The company focuses on creating novel drug candidates through a combination of chemistry, biology, and clinical expertise, ensuring a robust pipeline for future drug development. VIVOZON is committed to enhancing health and well-being by leveraging scientific advancements and efficacy-based screening in drug discovery. Their target clients include healthcare providers and patients seeking effective treatments for various neurological and pain-related conditions.Explore more
Vivozon Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vivozon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Vivozon has new funding data
Check out if Vivozon is spiking on competitors!
Click to see if Vivozon had a recent Job posting/layoffs
Product Launch: Get notified when Vivozon launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Vivozon recently announced quarterly report
Vivozon, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Vivozon has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Vivozon
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Vivozon
Find more new buyers
Compare Similar Companies to Vivozon
Compare insights from companies similar to Vivozon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vivozon is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vivozon is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vivozon.
Vivozon financials insights
Gather financial insights about Vivozon, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$120K
Vivozon Tech Stack
A closer look at the technologies used by Vivozon
Vivozon News & Media
Veeva Vault CDMS Selected for Vivozon’s VVZ-149 Studies
PLEASANTON, Calif.--(BUSINESS WIRE)--#CDMS--Vivozon selected Veeva Vault CDMS to provide EDC, coding, and data cleaning for their upcoming studies of VVZ-149 to treat post-operative pain.Vivozon's Non-Opioid Pain Killer has been granted the FDA's Fast Track Designation through Regulatory Strategy Support from MMS
CANTON, Mich., Nov. 8, 2018 /PRNewswire/ -- MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced that the company has successfully assisted Korea-based Vivozon Inc. in achieving a Fast Track Designation from the Food and Drug Administration (FDA) for VVZ-149, a...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Vivozon
Sign Up For FreeTo access detailed company insights
VIVOZON is a pharmaceutical company specializing in the development of innovative non-narcotic analgesics, including Opiranserin (VVZ-149), aimed at treating pain and central nervous system disorders such as depression, anxiety, and addiction. The company focuses on creating novel drug candidates through a combination of chemistry, biology, and cli... Read More
